Related Experiment Videos
Targeting the epidermal growth factor receptor: a clinical reality
1Vall d'Hebron University Hospital, Barcelona, Spain. baselga@hg.vhebron.es
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.
European journal of cancer (Oxford, England : 1990)·2017
Oncologist use and perception of large panel next-generation tumor sequencing.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026